Background : Ambulatory chemotherapy is very effective in the treatment of spinal tuberculosis, involving vertebral bodies, without paraplegia. However, some patients with thoracic disease could develop worsening of kyphosis. It would be helpful to predict which patients were unlikely to develop severe kyphosis.
Methods :
Step-wise discriminant analysis on the 10-year data of 79 patients treated with ambulatory chemotherapy showed that the angle of kyphosis on admission and the site of the lesion were associated with an angle of 50 0 or less at 10 years. An equation based on these factors was evolved to give a discriminant function (D) value. 
Introduction
Spinal tuberculosis is a common disease, especially in developing countries such as India. Ambulatory chemotherapy is very effective in patients having tuberculosis of 7 . It is therefore important to identify, at the start of treatment, patients unlikely to develop severe kyphosis. We have done extensive analyses of the data of a 10-year report on short-course chemotherapy for tuberculosis of the spine 1 , to evolve a reliable method to identify at start patients who could be successfully treated with ambulatory chemotherapy.
Patients and Methods
The subjects were 79 patients with tuberculosis involving the first thoracic to the second lumbar (T 1 -L 2 ) vertebral bodies 1 . They were treated with ambulatory chemotherapy alone, namely, daily isoniazid and rifampicin, given for either 6 months (41 patients) or 9 months (38 patients). Of the 79 patients, 43 were males and 36 were aged less than 15 years. The site of the lesion was thoracic in 57 and thoraco-lumbar or lumbar (up to L 2 ) in 22. The number of vertebrae affected was 2 or less in 54 and the total vertebral body loss was 1.0 or less in 50. The angle of kyphosis on admission was 30 ° or less in 62 %; none had more than 60°. A kyphosis of 50 0 or less is considered to be acceptable deformity for this study as the upper limit of normal thoracic kyphosis 8, 9 is 50 0 .
Statistical methods:
Step-wise linear discriminant analysis 10 , using the Statistical Package for Social Sciences (SPSS) software (release 4.0), was undertaken to determine the best combination of pre-treatment factors that could identify patients unlikely to have a kyphosis angle of more than 50 0 by 10 years. The pre-treatment factors considered were sex, age, site of lesion, number of vertebrae involved, total vertebral body loss, kyphosis angle and duration of chemotherapy. In the discriminant function equation, the appropriate pretreatment values were substituted for each patient to arrive at the discriminant function (D) value. An equation based on the angle of kyphosis on admission (A: p <0.0001) and the site a of the lesion (a : coded as 1 for thoracic and 2 for thoraco-lumbar or lumbar) (S: p < 0.03) gave the best discrimination. The discriminant function equation was as follows:
Using the theoretical critical D value of 0.500, the patients were classified as those predicted to have a kyphosis angle not exceeding 50 0 at 10 years (D=0.499 or less) and those predicted to have a 10-year angle exceeding 50 0 (D=0.500 or more). Considering an observed angle of 50 0 or less at 10 years, the prediction was correct if the 10-year predicted angle was also 50 0 or less; it was incorrect (false-positive) if the predicted angle was more than 50 0 . In the case of an observed angle of more than 50 0 at 10 years, the prediction was correct if the 10-year predicted angle exceeded 50 0 ; it was incorrect (false-negative) if the predicted angle was less than 50 0 .
Results
Of the 79 patients, the observed angle at 10 years was 50 0 or less in 51 patients and more than 50 0 in 28 patients. Table I gives the prediction results based on discriminant function values. A D-value of 0.499 or less had a prediction accuracy of 92 % (95 % confidence limits: 84.8-99.5%). The false-negativity rate was 18 %. Since the initial angle of kyphosis was a much more important factor (p<0.0001) than the site of the lesion (p< 0.03), analyses were undertaken to assess the prediction accuracy of the angle of kyphosis on admission when considered by itself. The distribution of various initial angles with reference to an observed angle of 50 0 or less at 10 years were scrutinized. For example (Table II) , an initial angle of 25 0 or less had a prediction accuracy of 61% only; an initial angle of 35 0 or less had a false-negativity rate of 25 % . An initial angle of 30 0 or less gave the best overall results (Table III) . Thus, it had a prediction accuracy of 90 % (95 % confidence limits: 82.0-98.4 % ) and false-negativity of 11%. It will be of interest to know the proportion of patients having an observed kyphosis angle of 50 0 or less at different time points after the start of treatment (Table IV) . Of 49 patients having an angle of 30 0 or less on admission, the proportion having an observed angle of 50 0 or less was 94 % at1½ years; this figure remained steady till 10 years. Considering 30 patients with an initial angle greater than 30 0 , the proportion of patients who had an observed angle of 50 0 or less was Considering patients with complications initially, there were 12 patients who had clinically evident abscess/sinus. The lesions resolved in all 12 on the prescribed chemotherapy. In all, 9 patients had paraparesis (but able to walk across a room) on admission. This condition resolved in all 9 patientsin 6 on the scheduled treatment and in the remaining 3 with surgery.
Discussion
Detailed analyses of the pre-treatment factors had shown that the angle of kyphosis on admission was the most important factor (p < 0.0001) for predicting which patients were likely to have a kyphosis of 50 0 or less at 10 years. Thus if the angle on admission was 30 0 or less, the angle at 10 years was likely to be 50 0 or less. This correctly identified 46 out of 51 (90 %) patients who had an observed angle of 50 0 or less at 10 years. The result achieved with the angle alone was not improved by using a discriminant equation (which required calculation) involving the site of the lesion in addition to the initial angle. It was also observed that 90-94% of patients having a kyphosis angle of 30 0 or less on admission had an observed angle not exceeding 50 0 between 1½ and 10 years. Therefore, if a patient has a kyphosis angle of 30 0 or less initially, he could be prescribed ambulatory chemotherapy provided he has no complications such as neurological deficit. This is in conformity with an earlier recommendation that "patients with an initial kyphosis angle of 30 0 or less should be started on ambulant chemotherapy"
1 . This observation was based on mean angles and the present analysis, based on discriminant analysis, confirms the earlier observation. To our knowledge, no other workers have undertaken detailed statistical analyses and derived a basis for prescribing ambulatory chemotherapy with confidence.
There were 3 patients who had an initial angle of 30 0 or less but an observed angle exceeding 50 0 at 10 years. It would be undesirable to continue these 3 patients on ambulatory chemotherapy. Hence, we recommend that all patients who are started on ambulatory chemotherapy be monitored and suitable action taken if there is progression of kyphosis 11 (or any other complication).
It was observed that among patients having a kyphosis angle exceeding 30 0 initially, 43 % had an observed angle of more than 50 0 at 1½ years and 83 % at 10 years. Hence, it is advisable that for all patients with an initial kyphosis angle of more than 30 0 , a decision on the appropriate method of treatment is taken on an individual basis.
Rajasekaran and Shanmugasundaram
12 reported that the angle of gibbus deformity at 6 years was predictable with 90% accuracy by using a linear regression equation based on the initial vertebral body loss. But this finding was not confirmed in a Chennai study 1 , in which the agreement (±10 0 ) between the predicted and observed 10-year angles was 34 to 43 %. Furthermore, predicting the actual angle likely is not necessary. What is required is to predict whether a patient considered for ambulatory chemotherapy is likely to develop severe kyphosis after the start of treatment.
Rajasekaran 13 has evolved a spinal instability score, based on radiological signs developing during the course of the disease in children under 15 years of age receiving chemotherapy. He reported that 89% of 37 patients with an instability score of 2 or less had a deformity of less than 30 0 at 15 years. This supports our recommendation to prescribe ambulatory chemotherapy for those with an initial angle of 30 0 or less on admission.
It is concluded that ambulatory chemotherapy could be confidently prescribed to spinal tuberculosis patients if the initial angle of kyphosis is 30 0 or less. This method is reliable because it identifies 9 out of 10 patients fit for ambulatory chemotherapy; it is simple because it requires just one measurement-that of the kyphosis angle on admission. We believe that our method would be of great use to treatment providers who have to take quick decisions regarding the line of treatment for large numbers of patients with spinal tuberculosis.
